Bioinorganic chemistry of Alzheimer's disease
KP Kepp - Chemical reviews, 2012 - ACS Publications
Alzheimer's disease (AD) 1− 3 is the most common form of dementia (estimated∼ 50− 60%
of all cases), associated with loss of memory (in particular episodic memory), cognitive …
of all cases), associated with loss of memory (in particular episodic memory), cognitive …
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD
L Mosconi - European journal of nuclear medicine and molecular …, 2005 - Springer
The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …
the development of preventive strategies. Neuropathology and structural MRI studies have …
The thyroid‐brain interaction in thyroid disorders and mood disorders
M Bauer, T Goetz, T Glenn… - Journal of …, 2008 - Wiley Online Library
Thyroid hormones play a critical role in the metabolic activity of the adult brain, and
neuropsychiatric manifestations of thyroid disease have long been recognised. However, it …
neuropsychiatric manifestations of thyroid disease have long been recognised. However, it …
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
High fat diets and sedentary lifestyles are becoming major concerns for Western countries.
They have led to a growing incidence of obesity, dyslipidemia, high blood pressure, and a …
They have led to a growing incidence of obesity, dyslipidemia, high blood pressure, and a …
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease
Y Jung, JS Damoiseaux - Brain, 2024 - academic.oup.com
Over the past several years, there has been a surge in blood biomarker studies examining
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Background: Few studies have compared the accuracy of [18F] fluorodeoxyglucose (FDG)
PET to the accuracy of clinical and pathologic diagnosis in dementia patients. Methods …
PET to the accuracy of clinical and pathologic diagnosis in dementia patients. Methods …
The role of neurovascular system in neurodegenerative diseases
The neurovascular system (NVS), which consisted of neurons, glia, and vascular cells, is a
functional and structural unit of the brain. The NVS regulates blood-brain barrier (BBB) …
functional and structural unit of the brain. The NVS regulates blood-brain barrier (BBB) …
Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory
Alzheimer's disease is the most common cause of dementia in older adults. Although the
cognitive deficits and pathologic hallmarks of Alzheimer's disease have been well …
cognitive deficits and pathologic hallmarks of Alzheimer's disease have been well …
Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET
A Drzezga, T Grimmer… - Journal of Nuclear …, 2005 - Soc Nuclear Med
Patients with mild cognitive impairment (MCI) represent a risk population for progressing to
dementia of the Alzheimer type (DAT). However, clinical criteria do not ensure reliable …
dementia of the Alzheimer type (DAT). However, clinical criteria do not ensure reliable …
Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
PM Kidd - Alternative Medicine Review, 2008 - search.ebscohost.com
Alzheimer's disease (AD) is the most common form of dementia. AD initially targets memory
and progressively destroys the mind. The brain atrophies as the neocortex suffers neuronal …
and progressively destroys the mind. The brain atrophies as the neocortex suffers neuronal …